Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 12,994 shares at $44.80 ($593K) on 2021-04-01, disclosed to the SEC on 2021-04-06.
Open-market sale of $593k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.80 | 2,100 | $94K | 15.9% |
| 2 | $45.69 | 4,994 | $228K | 38.5% |
| 3 | $45.69 | 4,994 | $228K | 38.5% |
| 4 | $46.72 | 906 | $42K | 7.1% |
| Total | $45.62 avg | 12,994 | $593K | 100% |
| Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |
| DCPH | SELL | 2020-12-03 | $2.3M | — | Filing → |